22 U.S.C. § 7652 — Policy and requirements

(a) Policy: U.S. government policy on the global HIV/AIDS pandemic should give top priority to preventing mother-to-child transmission, caring for and treating family members and caregivers, and caring for children orphaned by AIDS. As much as possible, the government should try to match its funds with contributions from private companies, other national governments, and international organizations. (b) Requirements: The 5-year U.S. government strategy required under section 7611 must: (1) set a target to reach at least 80 percent of pregnant women in the hardest-hit countries with prevention and treatment for mother-to-child HIV transmission by 2013; (2) set a target so that, by 2013, the share of children getting care and treatment under this chapter matches their share among all HIV-infected people in each country; (3) combine care-and-treatment programs with mother-to-child prevention programs as soon as possible, to help mothers and children get consistent follow-up care; (4) expand programs caring for children who are orphaned, affected, or made vulnerable by HIV/AIDS; (5) make sure women in prevention programs get, or are referred to, proper maternal and child health services; and (6) create a timeline for expanding access to more effective prevention regimens, matching each country's own policies, aiming for universal use as soon as possible. (c) Prevention of Mother-to-Child Transmission Expert Panel: (1) Establishment: The Global AIDS Coordinator must set up a panel of experts — the "Prevention of Mother-to-Child Transmission Panel" — to objectively review mother-to-child transmission prevention activities and recommend to the Coordinator and Congress how to scale up these services to hit the target in (b)(1). (2) Membership: The Coordinator chairs the Panel as a non-voting member and appoints up to 15 other members within 1 year of July 30, 2008, including 2 from Health and Human Services, 2 from USAID, 2 health ministers from countries with programs under this chapter, 3 from organizations running prevention programs, 2 health researchers, and others such as patient advocates, health professionals, people living with HIV/AIDS, and nongovernmental organizations — giving priority to people from the countries where these programs run. (3) Duties of Panel: The Panel must assess how well current efforts are meeting the (b)(1) target; review the scientific evidence, including program and clinical-trial data; review how the Coordinator's office works with international and multilateral partners on prevention; identify barriers to expanding access and ways to overcome them; identify how stigma keeps pregnant women from getting tested or returning for results, and recommend fixes; find ways to better connect prevention services with care and treatment programs; and recommend specific steps to help reach the (b)(1) target. (4) Report: Within 1 year of first convening, the Panel must send Congress a detailed report of its findings and recommendations. That report must be made public. The Coordinator must consider the recommendations and, in the required annual report under section 2151b–2(f), describe what was done in response and explain any recommendations not carried out. (5) Authorization of appropriations: Congress may appropriate whatever funds are needed for the Panel for fiscal years 2009 through 2011. (6) Termination: The Panel ends 60 days after it submits its report to Congress.